Sr Scientist, Biomarker at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Strong experimental background and experience in hypothesis-driven biological/translational research
Demonstrated ability to execute well-designed experiments in immunology and/or oncology
Ability to provide scientific leadership and disease biology direction, with a focus on tumor biology integrated with immunology/immuno-oncology
Experience creating and executing high-quality integrated discovery and translational plans for early programs at preclinical and clinical stages
Strong scientific communication and interaction skills with external collaborators, key opinion leaders, and academic sites
Experience analyzing early and late-stage clinical trials with multi-dimensional human data sets (e.g., genomic, epigenetic, gene expression, metabolomics, multiplexed protein detection, or emerging platforms)
Ability to work effectively in a dynamic multidisciplinary matrixed team environment
Experience leading and supporting biomarker efforts for late-stage or early development programs

Responsibilities

Generate and interpret data from translational and clinical studies
Design biomarker experiments and provide biomarker expertise to discovery and development project teams
Ensure access to state-of-the-art thinking on appropriate biomarker and diagnostic technologies
Provide input on clinical protocols and associated documents
Participate in meetings with regulatory authorities
Direct the implementation of clinically applicable biomarker assays (e.g., pharmacodynamic, predictive, prognostic, and other biomarkers)
Oversee biomarker testing and data analysis in collaboration with functional area representatives, diagnostic team, Clinical Development, and Research partners
Lead cross-functional teams to achieve biomarker and translational objectives

Skills

Biomarker

Immunology

Oncology

Tumor Biology

Immuno-oncology

Translational Research

Hypothesis-driven Research

Scientific Leadership

Preclinical Studies

Clinical Studies

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free